History of the DUDIT Test - From Karolinska Institutet to Clinical Practice
The DUDIT test was developed by a research team led by Anne H. Berman at the Karolinska Institutet in Stockholm. The first validation study was published in 2005 in Drug and Alcohol Dependence. The tool was designed as an equivalent of the AUDIT test (WHO) - but for psychoactive substances other than alcohol.
Why was DUDIT created?
Until the mid-2000s, there was no short, standardised drug screening test suitable for use in primary care, emergency departments and treatment centres. Existing tools (DAST, ASSIST) were either too long or did not account for gender differences in diagnostic thresholds. DUDIT filled this gap - 11 questions, completion time under 5 minutes, separate thresholds for women and men.
Validation
The original validation study included 160 participants (clinical and control groups). The Polish version demonstrates high internal reliability: Cronbach's α = 0.92. The test has been translated into over 20 languages and is used in Sweden, Norway, the UK, Iran and Poland, among others.
Test Structure - 11 Questions Across 4 Diagnostic Areas
DUDIT consists of 11 questions covering four areas: frequency of use, loss of control, impact on daily functioning, and health and social consequences.
Questions 1-4: Patterns of use
Assess the frequency of reaching for psychoactive substances, the number of substances used simultaneously and how often intoxication occurs. These cover all substances other than alcohol: cannabis, amphetamines, cocaine, opioids, benzodiazepines, hallucinogens, inhalants and others.
Questions 5-9: Dependence and loss of control
Assess symptoms of dependence syndrome: increasing tolerance, compulsive substance use despite negative consequences, inability to limit use and neglect of responsibilities. These questions correspond to ICD-10/DSM-5 diagnostic criteria for substance use disorders.
Questions 10-11: Consequences
Cover health, social and legal harm. These use a different scoring scale: 0, 2 or 4 points (without intermediate values). Question 11 asks whether anyone in the person's circle has expressed concern about their substance use.
Scoring
Questions 1-9: scale 0-4 pts. Questions 10-11: 0, 2 or 4 pts. Maximum score: 44 points.
Interpreting Results - Gender-Specific Diagnostic Thresholds
DUDIT uses different score thresholds for women and men. Research has shown that women develop substance-related problems at lower levels of exposure - hence the lower cut-off.
Men
| Score | Interpretation | Recommended intervention |
|---|---|---|
| 0 pts | No indication | Prevention |
| 1-6 pts | Low-risk substance use | Education, monitoring |
| 7-24 pts | Problematic use | In-depth assessment, specialist consultation |
| ≥25 pts | High probability of dependence | Referral for addiction treatment |
Women
| Score | Interpretation | Recommended intervention |
|---|---|---|
| 0 pts | No indication | Prevention |
| 1 pt | Occasional use | Education, monitoring |
| 2-24 pts | Problematic use | In-depth assessment, specialist consultation |
| ≥25 pts | High probability of dependence | Referral for addiction treatment |
The ≥25 point threshold is identical for both genders and indicates a high probability of dependence requiring specialist treatment.
DUDIT vs Other Tests - Comparison with DAST, ASSIST and DUDIT-E
DUDIT is not the only screening tool for psychoactive substances. Each has a different scope of application.
DUDIT vs DAST
DAST (Drug Abuse Screening Test) - 28 or 10 questions (abbreviated DAST-10). Uses yes/no answers, does not differentiate thresholds by gender and does not assess frequency of use. DUDIT better identifies individuals with problematic (but not dependent) patterns of use.
DUDIT vs ASSIST
ASSIST (WHO Alcohol, Smoking and Substance Involvement Screening Test) is more comprehensive - it covers alcohol, tobacco and drugs in a single questionnaire. It has 8 questions for each substance separately, which extends completion time. DUDIT is faster when screening specifically for psychoactive substances other than alcohol.
DUDIT-E - extended version
DUDIT-E (Extended) is a supplementary questionnaire to DUDIT. It examines the positive and negative aspects of substance use from the patient's perspective - helping to understand the motivation behind drug use. Used primarily in treatment planning, not as a screening tool.
DUDIT Test Limitations - What the Questionnaire Cannot Detect
DUDIT is a screening tool - it does not provide a diagnosis. A diagnosis of substance use disorders can only be made by a psychiatrist or addiction specialist.
When might the result be inaccurate?
- Denial - substance users often conceal or minimise the problem, particularly in the context of court-ordered or occupational supervision.
- Novel/designer substances - the test asks generally about "drugs and other substances". Patients may not classify e.g. legal highs or mephedrone as drugs.
- Prescription medication - misuse of benzodiazepines, prescription opioids or pregabalin is not always perceived by patients as "drug use".
- Polysubstance use - DUDIT does not differentiate which substance causes the greatest harm. Additional assessment is essential.
DUDIT and toxicology testing
The test measures the patient's subjective assessment, not the presence of substances in the body. Laboratory tests (urine immunoassays, hair testing) provide objective data. Combining the questionnaire with laboratory testing gives the most complete clinical picture.
The DUDIT test is for informational purposes only and does not constitute a medical diagnosis. If your result causes concern, book a consultation with a specialist.
